- 5,606
- 472
- 83
What was the deal with PolyHeme? They declared bankruptcy and have ceased all operations. That was an expensive 220 million dollar trial.
The drug showed no hope?
The drug showed no hope?
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
I assume you're speaking of Quikclot, Papa? If so, the military is moving away from that last I heard.
They still want hemostatic agents, but there have been problems with some types causing an embolus.
I assume you're speaking of Quikclot, Papa? If so, the military is moving away from that last I heard.
They still want hemostatic agents, but there have been problems with some types causing an embolus.
Lucid, you bring up a good point about the other phase. In hospital, they really DO have the luxury of getting the blood type and giving the right blood, while PH we do not.
But I'm wondering if A) PolyHeme help a bit more with anemic pts, as opposed to just plain old trauma
and B ) if it'd be a better 50/50 mix with NS? Since they showed the NS control worked better, maybe mixing the goods of oxygen carrying items, WITH NS, would make a difference?
I know those scientist are smarter as a whole then me, but there are plenty of other ways they could have tested and tweaked.
I assume you're speaking of Quikclot, Papa? If so, the military is moving away from that last I heard.
They still want hemostatic agents, but there have been problems with some types causing an embolus.
Lucid, you bring up a good point about the other phase. In hospital, they really DO have the luxury of getting the blood type and giving the right blood, while PH we do not.
But I'm wondering if A) PolyHeme help a bit more with anemic pts, as opposed to just plain old trauma
and B ) if it'd be a better 50/50 mix with NS? Since they showed the NS control worked better, maybe mixing the goods of oxygen carrying items, WITH NS, would make a difference?
I know those scientist are smarter as a whole then me, but there are plenty of other ways they could have tested and tweaked.
I wonder what the results would have been if they had crossmatched blood types for a 3rd control.
Like, make PolyHeme from an A+ blood sample, and put it in an A+ pt, and see the results.
(Yes, I know it's supposed to be a general supplement, but it IS science, so more info never hurts)
PolyHeme showed some promise, but... there seems to have been no significant difference between people resuscitated with it vs. conventional resuscitative measures. Also, they uncovered that about 3% suffered myocardial damage from PolyHeme. It very well could have been the hgb toxicity... IOW: it's no better, and actually possibly worse than standard resuscitation methods. So... they pulled it.
I'd have to look at the study data to see for myself... I haven't followed PolyHeme for about 2 years, so any studies newer than about 2008, I'm just not familiar with.